Thermodynamic stability analysis of M-NISOLDIPINE (cas 113578-26-0) polymorphs
-
Add time:08/23/2019 Source:sciencedirect.com
Two polymorphic crystal forms of M-NISOLDIPINE (cas 113578-26-0) (1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-methylpropyl ester) were characterized by X-ray powder diffraction and IR-spectroscopy. The solubility of the two polymorphs in water at 25, 31, 37, 42, and 49 °C was investigated; the values obtained were used to calculate the thermodynamic parameters of the phase transition. The results show that the two forms A and B are enantiotropic. The temperature of polymorphic phase transition was 47 °C, and the values of ΔGA,Bθ, ΔHA,Bθ, and ΔSA,Bθ at 25 °C were 2.47, 36.01, and 112.48 J · mol−1 · K−1, respectively. Form A is thermodynamically stable below the transition temperature; it accorded with interaction energies of the two forms obtained from Density Function Theory (DFT) calculations on the hydrogen-bonding and π-stacking interactions. The character of the solid-state decomposition, studied using DSC analysis, showed that the activation energies of decomposition of the polymorphs A and B after melting at high temperatures were 109.80 and 59.14 kJ · mol−1, respectively. It is conclusion that melted states of polymorphs A and B reserved “the memories” of their respective crystalline state. Furthermore, phase transition of the polymorphs was not found under solid-state grinding conditions. Moisture sorption/desorption experiments showed that the two forms of m-nisoldipine are nonhygroscopic.
We also recommend Trading Suppliers and Manufacturers of M-NISOLDIPINE (cas 113578-26-0). Pls Click Website Link as below: cas 113578-26-0 suppliers
Prev:Short communicationStudy of in vitro metabolism of M-NISOLDIPINE (cas 113578-26-0) in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography–mass spectrometry
Next:Simultaneous determination of M-NISOLDIPINE (cas 113578-26-0) and its three metabolites in rat plasma by liquid chromatography–mass spectrometry) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ContributionsAntihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension08/29/2019
- Cyclic voltammetric behaviour of the O2/O2− redox couple at a HMDE and its interaction with nisoldipine08/28/2019
- Enantioselective assay of nisoldipine in human plasma by chiral high-performance liquid chromatography combined with gas chromatographic−mass spectrometry: applications to pharmacokinetics08/27/2019
- Validated LC–MS–MS method for determination of M-NISOLDIPINE (cas 113578-26-0) polymorphs in rat plasma and its application to pharmacokinetic studies08/26/2019
- Molecular and Cellular PharmacologyThe inhibitory effects of M-NISOLDIPINE (cas 113578-26-0) on the 5-hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells via Ca2+ antagonism and antioxidant mechanisms08/25/2019
- Simultaneous determination of M-NISOLDIPINE (cas 113578-26-0) and its three metabolites in rat plasma by liquid chromatography–mass spectrometry08/24/2019
- Short communicationStudy of in vitro metabolism of M-NISOLDIPINE (cas 113578-26-0) in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography–mass spectrometry08/22/2019
- Short communicationStudies on separation and pharmacokinetics of M-NISOLDIPINE (cas 113578-26-0) enantiomers in beagle dog plasma by LC/MS/MS08/21/2019
- Original articleOn the dimorphism and the pressure–temperature state diagram of racemic M-NISOLDIPINE (cas 113578-26-0), a dihydropyridine calcium ion antagonistSur le dimorphisme et le diagramme d’état pression-température de la M-NISOLDIPINE (cas 113578-26-0) racémique, une dihydroyridine antagoniste08/20/2019